Vesiculobullous skin reactions induced by COVID-19 mRNA vaccine: report of four cases and review of the literature.
作者信息
Coto-Segura P, Fernández-Prada M, Mir-Bonafé M, García-García B, González-Iglesias I, Alonso-Penanes P, González-Guerrero M, Gutiérrez-Palacios A, Miranda-Martínez E, Martinón-Torres F
机构信息
Dermatology Department, Hospital Alvarez Buylla, Mieres, Spain.
Vaccines Unit, Preventive Medicine and Public Health Department, Hospital Alvarez Buylla, Mieres, Spain.
出版信息
Clin Exp Dermatol. 2022 Jan;47(1):141-143. doi: 10.1111/ced.14835. Epub 2021 Sep 2.
Abstract
摘要
相似文献
1
Vesiculobullous skin reactions induced by COVID-19 mRNA vaccine: report of four cases and review of the literature.
Clin Exp Dermatol. 2022 Jan;47(1):141-143. doi: 10.1111/ced.14835. Epub 2021 Sep 2.
2
Enalapril and bullous eruptions.
BMJ. 1994 Nov 26;309(6966):1411. doi: 10.1136/bmj.309.6966.1411a.
3
Drug-induced linear immunoglobulin A disease.
Clin Dermatol. 1993 Oct-Dec;11(4):529-33. doi: 10.1016/0738-081x(93)90161-5.
4
Discovering vesiculobullous drug eruptions through dermatopathologic techniques.
Clin Dermatol. 1993 Oct-Dec;11(4):557-65. doi: 10.1016/0738-081x(93)90166-a.
5
Heparin induced bullous hemorrhagic dermatosis at a site distant from the injection. A report of five cases.
An Bras Dermatol. 2016 Nov-Dec;91(6):857-859. doi: 10.1590/abd1806-4841.20165418.
6
Vancomycin-induced linear IgA bullous dermatosis presenting as generalized fixed drug eruption.
J Cutan Pathol. 2019 Dec;46(12):979-981. doi: 10.1111/cup.13563. Epub 2019 Aug 21.
7
Pityriasis rubra pilaris-like eruption following administration of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine.
Clin Exp Dermatol. 2022 Jan;47(1):188-190. doi: 10.1111/ced.14878. Epub 2021 Sep 24.
8
Isoniazid-induced bullous skin reaction.
Allergy. 1999 Mar;54(3):294-6. doi: 10.1034/j.1398-9995.1999.00049.x.
9
Phenotypic spectrum of serious cutaneous-only adverse event following immunization with COVID-19 vaccines: a multicentre case series and literature review.
Clin Exp Dermatol. 2022 Mar;47(3):614-616. doi: 10.1111/ced.15003. Epub 2021 Dec 16.
10
Ciprofloxacin-induced immunoglobulin A disease.
Am J Emerg Med. 2010 Jun;28(5):641.e1-3. doi: 10.1016/j.ajem.2009.08.026. Epub 2010 Mar 25.
引用本文的文献
1
Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system.
Front Med (Lausanne). 2025 Jan 23;12:1521697. doi: 10.3389/fmed.2025.1521697. eCollection 2025.
2
Meningitis after COVID-19 vaccination, a systematic review of case reports and case series.
BMC Infect Dis. 2024 Oct 10;24(1):1138. doi: 10.1186/s12879-024-10043-6.
3
New Onset and Exacerbation of Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Systematic Review.
Vaccines (Basel). 2024 Apr 26;12(5):465. doi: 10.3390/vaccines12050465.
4
[Blisters in a "cluster of jewels"-like pattern in a child with chronic hepatitis B infection].
Dermatologie (Heidelb). 2024 Feb;75(2):176-178. doi: 10.1007/s00105-023-05270-y. Epub 2023 Dec 13.
5
Side effects of COVID-19 vaccines in the middle eastern population.
Front Immunol. 2023 Nov 3;14:1270187. doi: 10.3389/fimmu.2023.1270187. eCollection 2023.
6
Vesiculobullous and Other Cutaneous Manifestations of COVID-19 Vaccines: a Scoping and Narrative Review.
J Cutan Med Surg. 2023 May-Jun;27(3):260-270. doi: 10.1177/12034754231156561. Epub 2023 Feb 15.
7
Autoimmune bullous diseases during COVID-19 pandemic: 2022 update on rituximab and vaccine.
Front Med (Lausanne). 2023 Jan 19;10:1112823. doi: 10.3389/fmed.2023.1112823. eCollection 2023.
8
Linear IgA bullous dermatosis after COVID-19 vaccination.
Int J Dermatol. 2023 Feb;62(2):e56-e58. doi: 10.1111/ijd.16541. Epub 2022 Dec 5.
9
Association between COVID-19 vaccination and bullous pemphigoid - a case series and literature review.
SAGE Open Med Case Rep. 2022 Oct 17;10:2050313X221131868. doi: 10.1177/2050313X221131868. eCollection 2022.
10
SARS-CoV-2 Infection and Vaccination Cutaneous Manifestations for the Inpatient Dermatologist.
Curr Dermatol Rep. 2022;11(4):252-262. doi: 10.1007/s13671-022-00374-5. Epub 2022 Oct 19.
本文引用的文献
1
Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021.
Euro Surveill. 2021 May;26(21). doi: 10.2807/1560-7917.ES.2021.26.21.2100438.
2
Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2.
N Engl J Med. 2021 Apr 1;384(13):1273-1277. doi: 10.1056/NEJMc2102131. Epub 2021 Mar 3.
3
Letter to Editor: Oral lesions in a patient with Covid-19.
Med Oral Patol Oral Cir Bucal. 2020 Jul 1;25(4):e563-e564. doi: 10.4317/medoral.24044.
4
Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.
Clin Immunol. 2020 Aug;217:108480. doi: 10.1016/j.clim.2020.108480. Epub 2020 May 24.
5
Bullous Drug Reactions.
Acta Derm Venereol. 2020 Feb 12;100(5):adv00057. doi: 10.2340/00015555-3408.
6
Linear IgA Bullous Dermatosis: A Series of 17 Cases.
Actas Dermosifiliogr (Engl Ed). 2019 Oct;110(8):673-680. doi: 10.1016/j.ad.2018.06.017. Epub 2019 Apr 20.
7
Drug-induced pemphigoid: a review of the literature.
J Eur Acad Dermatol Venereol. 2014 Sep;28(9):1133-40. doi: 10.1111/jdv.12366. Epub 2014 Jan 10.
8
Bullous pemphigoid triggered by swine flu vaccination: case report and review of vaccine triggered pemphigoid.
J Dermatol Case Rep. 2011 Dec 12;5(4):74-6. doi: 10.3315/jdcr.2011.1081.
Zotero 插件